MEDTECH
INDUSTRIAL CAMPUS
WHERE INNOVATION MEETS INDUSTRY
DISRUPTIVE TECHNOLOGIES TO IMPROVE HEALTHCARE AND HUMANITY ‘S QUALITY OF LIFE.
At the crossroads of Health and Technology, tomorrow's medicine will be predictive, preventive powered by AI and quantic technologies.
Medical devices with technologies that “repair” Man.
We are redefining healthcare thanks to miniaturized, intelligent, high-performance medical devices for a better quality of life for patients.
Overcoming paraplegia, blindness, depression, heart failure, and Alzheimer's disease is no longer fiction.
Start-ups are developing technologies and devices to fix Man’s health problems – better and faster than ever before.
The DOLIAM Group - 40 years of technological expertise in cutting-edge fields driven by patient care.
A unique expertise forged by its DNA as an industrial group
of high-tech SMEs.
The DOLIAM Group is at the heart of the High-Tech Healthcare industry and brings together several MedTech, DeepTech, and healthcare companies, from start-ups to industrial-scale companies, developing technologies and products with high scientific and technological added value. With over 550 employees in France and the United-States,
Through its investments, DOLIAM explores uncharted scientific territories, supporting new ideas that can change Humanity through products and services it helps to create and develop. With a realistic assessment of market potential, DOLIAM is discerning and only invests in companies it believes in. It supports their growth, from idea to strategic direction and operational execution, opening up new market segments with potential global impact.
HOWEVER, THE JOURNEY TO BRING DISRUPTIVE IDEAS TO MARKET IS LONG, TEDIOUS, AND CASH-HUNGRY.
Indeed, the complex industrialization of medical devices requires specific infrastructures and expertise.
The current market environment is heterogeneous and limited, and industrialization is ill-suited to market needs and, ultimately, patients’ needs.
A difficult situation rife with opportunities
Opportunities exist in this fast-growing global MedTech market, which is driven by longer life expectancy, chronic diseases, and 5P medicine.
The 600 bn USD global MedTech market, 1/3 of which is in Europe, is driven by an aging population, an increase in chronic diseases, and technological development. The rise of microelectronics in healthcare has opened a wide range of applications, from medical imaging to in vitro diagnostics and AIMD.
These findings have given rise to a project that is equal to the needs and expectations:
The MedTech Industrial Campus
The missing link in
the MedTech Industry
MedTech Industrial Campus is
an industrial tool and accelerator that
shortens the time-to-market for start-ups and medical devices.
The industrial bridge between breakthrough technologies and patients.
A unique industrial campus in Europe to accelerate the time-to-market for medical devices from the sector's future majors, with a unique value proposition: pooling infrastructures and resources to provide comprehensive support for emerging MedTech players, from R&D to industrialization.
Meeting the demand for industrialization in the MedTech industry.
MedTech Industrial Campus is a powerful industrial tool that will help overcome these difficulties.
Supported at the highest level of government by France 2030 - AIS (Agence Innovation en Santé), the Banque des Territoires, and BPI, the MIC will be a genuine catalyst, bringing together the key players in the sector: laboratories, subcontractors, experts, teacher-researchers, and public and private partners.
